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Abstract. 
 
The characterization of 
 
scully
 
, an essential 
gene of 
 
Drosophila
 
 with phenocritical phases at embry-
onic and pupal stages, shows its extensive homology 
 
with vertebrate type II 
 
l
 
-3-hydroxyacyl-CoA dehydro-
genase/ERAB. Genomic rescue demonstrates that four 
different lethal mutations are 
 
scu
 
 alleles, the molecular 
nature of which has been established. One of them, 
 
scu
 
3127
 
, generates a nonfunctional truncated product. 
 
scu
 
4058
 
 also produces a truncated protein, but it contains 
most of the known functional domains of the enzyme. 
The other two mutations, 
 
scu
 
174
 
 and 
 
scu
 
S152
 
, correspond 
to single amino acid changes. The expression of 
 
scully
 
 
mRNA is general to many tissues including the CNS; 
however, it is highest in both embryonic gonadal pri-
mordia and mature ovaries and testes. Consistent with 
this pattern, the phenotypic analysis suggests a role for 
 
scully
 
 in germ line formation: mutant testis are reduced 
in size and devoid of maturing sperm, and mutant ovar-
ioles are not able to produce viable eggs. Ultrastruc-
tural analysis of mutant spermatocytes reveals the pres-
ence of cytoplasmic lipid inclusions and scarce 
mitochondria. In addition, mutant photoreceptors con-
tain morphologically aberrant mitochondria and large 
multilayered accumulations of membranous material. 
Some of these phenotypes are very similar to those 
 
present in human pathologies caused by 
 
b
 
-oxidation 
disorders.
A
 
lthough
 
 energy storage and metabolism have been
well-studied in 
 
Drosophila
 
 (Clark, 1989), the en-
zymes implicated in fatty acid oxidation have not
 
been characterized, and the phenotypes associated with
genetic alterations in this metabolic pathway have not
been described. 
 
b
 
-oxidation is a major metabolic process
by which fatty acids are oxidized to provide a significant
source of energy, while also generating acetyl-CoA, a me-
tabolite that is located at the crossroads of many metabolic
routes. In mammals, hepatic 
 
b
 
-
 
oxidation provides circulat-
ing ketone bodies. These ketone bodies are a very impor-
tant fuel for other organs—especially the brain—when
blood glucose levels are low, for example, during long-lasting
exercise or starvation. By contrast, in muscles, 
 
b
 
-
 
oxidation
is almost exclusively used to obtain energy from complete
oxidation of acetyl-CoA. In animal cells, both mitochon-
dria and peroxisomes are the subcellular organelles where
 
b
 
-
 
oxidation takes place (reviewed by Mannaerts and Van
Veldhoven, 1996; Eaton et al., 1996), but the mitochon-
drion is the main site of energy production. As a second-
ary product of mitochondrial aerobic respiration, reactive
oxygen species are generated (Boveris et al., 1973). Also,
mitochondria are important storage sites for intracellular
calcium, and are necessary for intracellular calcium buffer-
ing (Gunter et al., 1994). Currently, mitochondria are con-
sidered a triggering factor in the onset of many neurode-
generative diseases (Beal et al., 1993; Sims, 1996).
During one passage through the 
 
b
 
-
 
oxidation pathway,
saturated fatty acids with an even number of carbon atoms
release a pair of carbon residues. This release is achieved
by four consecutive reactions successively catalyzed by
acyl-CoA dehydrogenase, enoyl-CoA hydratase, 3-hydroxy-
acyl-CoA dehydrogenase (HADH),
 
1
 
 and 3-ketoacyl-CoA
thiolase. Over the last years, it has become clear that 
 
b
 
-
 
oxida-
tion pathway enzymes consist of specificity groups of iso-
enzymes that catalyze the same reaction, but differ in their
affinity for carbon chain length of the various substrates.
Complexity of this metabolic pathway is further increased
by tissue-specific isoenzymes. In mitochondria, the third
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step of the pathway was known to be catalyzed by two
HADHs with overlapping substrate chain-length specifici-
ties. Long-chain HADH is a trifunctional protein that cat-
alyzes the last three steps of 
 
b
 
 
 
oxidation. It is tightly asso-
ciated with the inner mitochondrial membrane, and is
active with medium and long chain–length substrates (El-
Fakhri and Middleton, 1982). In contrast, short-chain
HADH is a monofunctional soluble enzyme located in the
mitochondrial matrix that preferentially metabolizes short
chain–length substrates (He et al., 1989). However, a new
type of HADH has been recently characterized (Koba-
yashi et al., 1996) and cloned (Furuta et al., 1997) from bo-
vine liver. Termed type II short chain HADH, it differs
from the classical isozyme (type I) in its primary structure,
and also in its molecular and catalytic properties. It is clear
now that the 
 
b
 
-
 
oxidation pathway conceals a more elabo-
rate specificity than previously thought.
Primary defects in mitochondrial function are impli-
cated in a growing number of human diseases (Luft, 1994;
Roe and Coates, 1995). Manifestation of these diseases are
thought to result from oxidative stress derived from en-
ergy imbalance. Oxidative stress, perhaps partly gluta-
mate-mediated, has also been implicated in some age-
related neurodegenerative diseases such as Parkinson,
Alzheimer, and Huntington diseases, and amyotrophic lat-
eral sclerosis (Beal et al., 1993; Coyle and Puttfarcken,
1993). In several inherited enzymopathies of the mito-
chondrial fatty acid 
 
b
 
-oxidation pathway (reviewed in Roe
and Coates, 1995), the affected enzymatic activity remains
unknown, partly as consequence of the emerging complex-
ity of the enzymatic repertoire. Studies of patients with
these genetic disorders suggest that mitochondrial 
 
b
 
-
 
oxi-
dation may be essential only during periods of high energy
demand such as fasting, febrile illness, or muscular exer-
tion. In addition, the levels of some of the 
 
b
 
-
 
oxidation mi-
tochondrial enzymes have been shown to increase only af-
ter birth (Lopaschuk et al., 1992; Hainline et al., 1993).
During prenatal development, 
 
b
 
-
 
oxidation seems to repre-
sent a minor energy source, and thus the role of the 
 
b
 
-
 
oxi-
dation enzymes in this period is not well understood.
In this study, we report the molecular characterization
of a 
 
Drosophila
 
 gene, 
 
scully
 
 (
 
scu
 
), that encodes a protein
with high structural homology to type II HADH. This is
the first enzyme related to 
 
b
 
-
 
oxidation that has been re-
ported in 
 
Drosophila
 
. Recently, the human homologue
 
ERAB 
 
has been shown to bind the amyloid-
 
b
 
 peptide, and
has consequently been related with Alzheimer’s disease
neuronal dysfunction (Yan et al., 1997). We also report the
phenotypes associated with different lethal alleles of this
gene. The mitochondrial phenotypes presented here sug-
gest an identical localization for this new protein with that
of its vertebrate counterparts. Striking similarities be-
tween the cellular phenotypes of 
 
scu
 
 mutants and the hu-
man pathologies associated with alterations in this meta-
bolic pathway are discussed.
 
Materials and Methods
 
Fly Culture and Strains
 
Flies were grown and collected under standard conditions (Ashburner,
1989). We used Canton-S (CS) as the wild-type stock. Lethal mutations
 
scu
 
174
 
 and 
 
scu
 
4058
 
 were induced by ethyl methanesulphonate (EMS) and x
ray, respectively, on a 
 
f
 
5
 
 os
 
-marked chromosome (Ferrús et al., 1990). 
 
scu
 
3127
 
was induced by EMS on a 
 
y w hdp
 
3
 
-marked chromosome. 
 
scu
 
S152
 
 was gener-
ated by EMS mutagenesis, and was kindly provided by Dr. N. Perrimon
(Department of Genetics, Harvard Medical School, Boston, MA). All mu-
tations were kept either balanced with chromosome 
 
FM6
 
 or covered by du-
plication 
 
Dp(1,3)JC153
 
 (stock was 
 
C[1]M3/scu*;Dp[1;3]JC153/TM3
 
).
 
Biology of Mutants: Mosaics and Lethal Phase Analysis
 
To determine the lethality phase, 
 
scu*
 
/
 
1
 
 females were crossed to CS
males. We allowed fertilized females to lay eggs for a 24-h period at 25
 
8
 
C.
Groups of 20–30 eggs were examined at 1-d intervals. For generating twin
clones, progeny from the cross: 
 
y w scu*os
 
/
 
FM6
 
 
 
3 
 
f
 
5
 
 
 
os
 
 was x ray–treated
0–48 h after egg laying. The presence of somatic clones was monitored in
the cuticle of adult 
 
y w scu*os
 
/
 
f
 
5
 
 
 
os
 
 F1-females. A twin clone is composed
of two adjacent patches generated in the same event of recombination:
one marked with forked and the other with yellow, where the yellow clone
is homozygous for the lethal mutation 
 
scu*
 
. Single forked clones were
considered internal controls. Eye mosaics were generated in 
 
y w hdp
 
3
 
scu
 
3127
 
/
 
M(1)n
 
 flies that had been x ray–treated between 48 and 72 h of de-
velopment.
 
Isolation and Molecular Cloning of cDNA and
Genomic Clones
 
An adult MATCHMAKER cDNA library from 
 
Drosophila melanogaster
 
(CLONTECH Laboratories, Inc., Palo Alto, CA) was screened at high
stringency with the 422E1 genomic fragment (Fig. 1). Recombinant DNA
manipulations were performed using standard procedures (Sambrook et al.,
1989). All purified cDNA positives were sequenced by the dideoxy chain
termination method using a DNA sequencer (PE Applied Biosystems,
Foster City, CA). DNA sequence data were analyzed using DNAstar soft-
ware (DNASTAR Inc., Madison, WI), and comparisons were done using
the BLASTX program (Gish et al., 1993; Altschul et al., 1990). The com-
plete genomic sequence of 
 
scully
 
 gene has been submitted to the DDBJ/
EMBL/GenBank databases under accession No. Y15102.
 
Genomic Rescue
 
Genomic clones were previously obtained (described in Baumann et al.,
1987). EcoRI fragments were subcloned into pBluescript KS
 
1
 
 vector
(Stratagene, La Jolla, CA). For genomic rescue, EcoRI fragment 422E1
was inserted into the germ line transformation vector pCasper (Pirrotta,
1988). P element–mediated germline transformation was performed ac-
cording to described methods (Spradling and Rubin, 1982). Df(1)w flies
were the parental strain for all germline transformations.
 
Northern Blot Analysis
 
Poly(A)
 
1
 
 mRNA was isolated from different developmental stages of
 
Drosophila melanogaster
 
 CS strain using a QuickPrep Micro™ mRNA
purification kit (Pharmacia Biotech, Inc., Piscataway, NJ). The same
amount of mRNA (5 
 
m
 
g) for each sample was loaded on 1.2% agarose
formaldehyde gels and transferred onto nylon membranes (Nycomed
Amersham Inc., Princeton, NJ). The hybridization was in 50% forma-
Figure 1. Molecular map of scully transcription unit. scully is lo-
cated on the X chromosome 50 kb proximal to the Shaker gene
(Baumann et al., 1987) and 14 kb distal to the Troponin I gene
(Barbas et al., 1991). Lethality rescue was analyzed in transfor-
mants using the genomic EcoRI-fragment (2,4 kb) shown, termed
422E1. It contains the entire transcription unit, including the pro-
moter region. Relevant nucleotide signal sequences are indicated
(see text). Centromere is to the right.
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mide, 6
 
3
 
 SSC, 10
 
3
 
 Denhardt’s solution, and 100 
 
m
 
g/ml herring sperm
DNA using 2 
 
3 
 
10
 
6
 
 cpm/ml of random priming labeled probe (Feinberg
and Vogelstein, 1983). Finally, the filter was washed in 0.2
 
3
 
 SSC, 0.1%
SDS at 65
 
8
 
C. Exposure times ranged from several hours to 3 d. Loading
and transfer efficiency were monitored by staining the ribosomal RNA on
the nylon membrane with 0.05% methylene blue in 0.5 M sodium salicy-
late (pH 5.2). Usually, filters were further hybridized with Dras-1 probe to
quantify mRNA content in each lane (Neuman-Silberberg et al., 1984).
Transcript sizes were estimated using mRNA markers (Boehringer Mann-
heim Corp., Indianapolis, IN).
 
In Situ Hybridization
 
For in situ hybridization, we used a probe corresponding to the longest
cDNA. cRNA was labeled with digoxigenin and hybridized to 12-
 
m
 
m par-
affin sections according to Schaeren-Wiemers and Gerfin-Moser (1993)
with the following modification. Tissues were fixed in 4% paraformalde-
hyde in 0.1 M phosphate buffer (pH 7.5) for 24 h at 4
 
8
 
C. After embedding
and cutting, paraffin sections were deparaffinized in xylene, rehydrated
through a series of ethanol/PBS solutions, permeabelized in 1% Tween
for 30 min, and postfixed. Sections were prehybridized in 50% formamide,
1.3
 
3
 
 SSC (pH 4.5), 0.5% CHAPS, 0.2% Tween, 100 
 
m
 
g/ml heparine, 50
 
m
 
g/ml t-RNA, and 5 mM EDTA for 2 h at 65
 
8
 
C. Overnight hybridization was
performed at the same temperature and in the same solution with the probe
at a concentration of 500 ng/ml. Sections were then extensively washed in
0.2
 
3
 
 SSC at 65
 
8
 
C, passed to 0.1 M Tris-HCl, pH 7.5, 0.15 M NaCl, and
blocked with the addition of 10% normal goat serum and 0.1% Tween. After
incubating with anti-DIG-alkaline phosphatase (1:1,000; Boehringer Mann-
heim) and washing several times in 100 mM maleic acid, 150 mM NaCl, 2
mM levamisole (Sigma Chemical Co., St. Louis, MO) at pH 7.5, alkaline
phosphatase activity was developed with NBT/BCIP in 0.1 M Tris-HCl pH
9.5, 0.1 M NaCl, 50 mM MgCl
 
2
 
. Reaction was stopped in 1 mM EDTA.
 
Histological Procedures
 
Testes of white-to-light brown pupae (0–12 h after puparium formation)
of CS or 
 
scully
 
 mutants and adult mosaic eyes were dissected and prefixed
for 1 h in an ice-cold solution of 4% paraformaldehyde plus 1% glutaral-
dehyde in 0.1 M phosphate buffer, pH 7.2. After rinsing the specimens in
phosphate buffer, postfixation was performed in 2% OsO
 
4
 
 for 90 min in
the dark. Samples were dehydrated in an ascending alcohol series and em-
bedded in SPURR resin. Semithin sections (2 mm) were stained with
Toluidine blue. Ultrathin sections (60–70 nm) were contrasted with uranyl
acetate and lead citrate, and were examined using an electron microscope
(JEOL USA, Inc., Peabody, MA). For lipid staining, testes were dissected
in 5 mM Hepes pH 7.4 containing 115 mM sucrose, 100 mM NaCl, 5 mM
KCl, 20 mM MgCl
 
2
 
, and 0.15 mM CaCl
 
2
 
, fixed in 4% formaldehyde for
1 h, cryoprotected with 30% sucrose in 0.1 M phosphate buffer, pH 7.4,
and embedded in Tissue Tek™ (Salavra, The Netherlands). 10-
 
m
 
m cry-
ostat sections were stained with red oil O solution following a described
protocol (Humason, 1972).
 
Enzymatic Assay
 
Testes were dissected as above and homogenized in 50 mM Tris-HCl, pH
7.4. Crude extracts were assayed for the HADH reverse reaction as de-
scribed in Osumi and Hashimoto (1979) using acetoacetyl-CoA as sub-
strate. One enzyme unit corresponds to the amount of enzyme protein
that catalyzes the oxidation of 1 
 
m
 
M NADH/min. Reaction specificity was
monitored, omitting the substrate in a control assay. Protein content in ex-
tracts was quantified using the Protein Assay™ reagent (Bio-Rad Labora-
tories, Hercules, CA), and equal amounts of protein was used for compar-
ison of HADH activity in different extracts.
PCR Analysis of the Mutants
To find the molecular alterations of scu mutants, both larval genomic
DNA and cDNA were PCR-amplified under standard conditions (Innis
and Gelfand, 1990). The oligonucleotides used to amplify genomic DNA
were: 59-ccggatcctcactgtttgcctgctc-39 (sense) and 59-ccgaattccccgccagctgccc-
tac-39 (antisense). To amplify cDNA, we used the primers: 59-caggatc-
ctttcgcacccacaaca-39 (sense) and 59-ccgaattcgagccacttccacagg-39 (antisense).
The products of two independent amplifications were cloned in pBlue-
script and sequenced in each case to confirm any possible alteration found.
Results
Genetic Mapping of scully
The gene scully (scu) is defined as the complementation
group composed by the lethal mutations scu174, scu4058,
scu3127, and scuS152. These alleles have been mapped by re-
combination and segmental aneuploidies to the interval
between the Shaker (Sh; Baumann et al., 1987) and Tropo-
nin I (TnI; Barbas et al., 1991) genes in the 16F region of
the X chromosome. The genomic DNA between the Sh
and TnI transcription units extends over 65 kb, and has
been previously cloned (Baumann et al., 1987). Six inde-
pendent transcripts have been identified in this interval by
Northern blot analysis using different genomic probes (not
shown). To identify the genomic region containing the scu
gene, we generated transgenic flies carrying different ge-
nomic fragments, and tested their ability to rescue scu le-
thal mutations (see Materials and Methods). The smallest
fragment used, 422E1, spans 2.4 kb (Fig. 1) and completely
rescued the male lethality of the four alleles, but it did not
rescue any other complementation group present in the
area (data not shown). Three independent insertions of
this fragment were tested in the rescue experiments. These
results demonstrate that the scu gene is fully contained
within these 2.4 kb.
Molecular Characterization of the scully
Transcription Unit
Northern blot analysis of this transcription unit using the
genomic fragment 422E1 as a probe revealed a single 1.0-kb
transcript. Screening of an adult cDNA library with the
same fragment rendered four cDNA clones whose se-
quences were compared with that of the genomic counter-
part, and provided the gene structure represented in Fig. 1.
The transcription unit is composed of two exons separated
by a 551-bp intervening sequence. The intron/exon bor-
ders precisely match consensus splice sequences (Mount
et al., 1992). The four cDNAs start at different but nearby
sites, suggesting that initiation of transcription occurs close
to this region. A GCAGT sequence close to the first nu-
cleotide of the longest cDNA and preceded by an AT-rich
zone is a good candidate for a functional arthropod tran-
scription initiator (Cherbas and Cherbas, 1993). Further-
more, 20–40 nucleotides downstream of position 11 there
are three sequences—TCGA, AACA and ACAA—that
have been reported as downstream elements important for
initiation of transcription (Arkhipova, 1995). There is also
a TATA box–like sequence in the upstream genomic re-
gion. Finally, three of the cDNAs are polyadenylated at
the same site 18 nucleotides downstream of the polya-
denylation signal AUUAAA (Wickens and Stephenson,
1984). Thus, our analysis predicts a full-length mRNA of
1026 nucleotides in agreement with the size of the band
detected by Northern blot analysis.
scully Encodes a Short Chain
L-3-hydroxyacyl-CoA Dehydrogenase
All four cDNAs comprise a complete and identical open
reading frame of 765 nucleotides. The start codon 118ATG
matches the consensus sequence described for Drosophila
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(Cavener and Ray, 1991). Translation of the cDNA pre-
dicted a 255–amino acid protein with an estimated Mr of
27 kg/mol. A PROSITE pattern search of this protein se-
quence detected the consensus motif for short-chain alco-
hol dehydrogenase between amino acids 149 and 177. In
agreement, a basic local alignment search tool search re-
vealed a high degree of homology with proteins of the
short-chain dehydrogenase/reductase (SDR) family, identi-
fying the protein Scully as a new member. Highest homol-
ogy scores revealed a bovine protein (AB002156), biochem-
ically characterized as a new type of HADH (Furuta et al.,
1997), and its human counterpart (U73514; Zhuchenko et
al., unpublished data). The last sequence is identical to hu-
man ERAB (U96132), a protein that binds amyloid-b pep-
tide (ERAB) and mediates neurotoxicity in Alzheimer’s
disease (Yan et al., 1997). Fig. 2 shows the alignment of
Scully with the consensus sequence derived from its three
mammalian homologues. Based on the high degree of
identity between Scully and this consensus (61% along the
whole sequence), we propose that this new protein is the
Drosophila homologue of the enzyme l-3-hydroxyacyl-
CoA dehydrogenase type II, a new type of monofunc-
tional enzyme involved in the mitochondrial b-oxidation
of fatty acids. Scully and its homologues seem to define a
new subfamily in the SDR family of proteins.
Molecular Characterization of scully Mutations
Three alleles—scu174, scu3127, and scuS152—were induced
by EMS mutagenesis; scu4058 was generated by x rays.
Southern analysis detected an alteration only in scu3127. Se-
quencing of at least two independent PCR amplifications
of genomic DNA and cDNA from male third instar mu-
tant larvae identified the molecular alteration in each of
the four scu alleles (Fig. 2). scu3127 is a 254-bp deletion
within exon 2. The putative altered transcript encodes a
truncated peptide that contains the first 86 amino acids
followed by seven out-of-frame residues and a premature
stop codon. The other three mutations are point muta-
tions. In scu174 the codon change 1136CTGfi CAG results in
the amino acid substitution L33Q, affecting a residue that
is strictly conserved in all Scully homologues. In scuS152,
the mutation 1397TTC fi ATC produces the amino acid
substitution F120I in another well-conserved residue.
scu4058 is a deletion of two nucleotides (1651GG) that causes
a frame shift at E205 and generates a stop codon 60 nucle-
otides farther downstream. Note that in scu4058 the trun-
cated putative protein has both the catalytic center and the
site for cofactor binding, but lacks the carboxy terminal re-
gion that is supposed to confer substrate specificity (see
Discussion).
Developmental and Tissue Expression of scully
Expression of scu transcripts was analyzed by Northern
blot and in situ hybridization to paraffin sections. North-
ern analysis detected a single 1.0-kb band at all develop-
mental stages studied that displayed developmental quan-
titative differences. mRNA was low in unfertilized oocytes,
and increased during embryonic development (Fig. 3 a). In
adults, expression was higher in females than in males
(Fig. 3 a). mRNA in situ hybridization to late embryos
showed a very intense signal in the gonadal primordium
(Fig. 3 b). The high expression in gonads persisted through
all larval stages, during which other tissues, such as third
instar larvae imaginal discs, central nervous system, and
salivary glands also showed scu expression (Fig. 3 c). A
weaker signal is also observed in the gut epithelial cells
and malphigian tubules (not shown). In adults, the tran-
script was especially abundant in female abdomen where
signal appeared associated with nurse cells in the ovaries
(Fig. 3 d). In males, testes also maintained high levels of
mRNA (not shown).
scully Mutant Phenotypes
The developmental effects of scu mutations were analyzed
in different cell types in either entirely mutant or mosaic
flies. Analysis of the lethal phases revealed interallelic dif-
ferences (Table I). These differences were studied in detail
for three alleles: scu174, scu4058, and scu3127. scu174, which
encodes a protein with a single amino acid substitution,
and scu4058, which contains a small carboxy-terminal dele-
tion, exhibit an early lethal phase during the embryo stage,
followed by a major period of lethality around the onset of
metamorphosis. Interestingly, scu3127, which encodes a
protein truncated at its amino terminus, is completely via-
ble during embryonic development, and becomes lethal
only when larvae reach the late third instar. The molecular
alteration of scu3127 indicates that this is a functionally null
Figure 2. Scully and its mammalian homologues. Alignment of
Scully (upper row) and the mammalian consensus derived from:
Bos taurus type II l-3-hydroxyacyl-CoA dehydrogenase
(AB002156; Furuta et al., 1997); Homo sapiens ERAB (U96132;
Yan et al., 1997) and U73514 (Zhuchenko et al., unpublished
data); and Mus musculus ERAB (U96116; Fu et al., unpublished
data). Functional domains are boxed and shaded; the first is the
cofactor-binding domain and the second is the catalytic domain.
Single amino acid mutations scu174 and scuS152 are indicated with
asterisks. Frameshift mutations scu3127 and scu4058 are indicated
with arrowheads. Amino acids conserved in more than 90% of
the short-chain alcohol dehydrogenases sequences (Jörnvall et al.,
1995) are underlined. The complete genomic sequence of scully
gene has been submitted to the DDBJ/EMBL/GenBank data-
bases under accession No. Y15102.
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allele, and mutant survival during embryonic and larval
stages must result from the maternal normal product accu-
mulated during the oogenesis. By contrast, scu174 and
scu4058 behave as dominant negative (antimorphic) alleles;
they show earlier lethality that cannot be completely res-
cued by maternal protein.
We analyzed the in vivo effects of scully mutations in
mosaic adult flies with patches of mutant cells. Previously
it was reported that recovery of gynandromorphs for scu174
was extremely rare (10%), and male/mutant territories
were small and with few and short bristles (Ferrús et al.,
1990). Small somatic mosaics were produced in the cuticle
of individuals heterozygous for scu4058 or scu3127. Bristle
markers allowed to recognize the wild-type (1/1) and ho-
mozygous mutant (scu*/scu*) areas derived from a single
heterozygotic cell (twin mosaic analysis; see Materials and
Methods). Table II shows that the number of mutant
clones obtained was reduced with respect to the wild-type
controls in both alleles tested. This result indicates that
scully activity is required for cell survival, and that this re-
quirement is cell-autonomous. As in the previous trait,
there are differences between the two alleles. scu4058 was
incapable of generating mutant clones with more than one
cell, and, similar to scu174, the bristles were short and thin.
scu3127, however, was able to generate larger clones of nor-
mal morphology. Thus, the null mutation (e.g., scu3127)
also showed the mildest phenotype in mosaic analysis.
To analyze the effects of scully mutations on cell mor-
phology, we attempted to obtain larger patches of mutant
cells in the form of Minute1 clones (see Materials and
Methods). Eye mosaics of the allele scu3127 were recovered
at a frequency three times lower than that of controls.
Photoreceptor cells did not differentiate normally, and
ommatidia were not recognizable in the mutant territory
(Fig. 4 a). Ultrastructural analysis of these mosaics re-
vealed putative photoreceptor cells that were unable to
Figure 3. scully expression pattern. (a) Northern blot showing
the 1.0-kb scu mRNA band detected with the genomic probe
422E1 (top). Total mRNA per lane was controlled by subsequent
hybridization with a probe for d-ras 1 mRNA. In situ hybridiza-
tion to sections of (b) late embryo; (c) third instar larva; and (d)
adult female. u, unfertilized eggs; e, 0–48 h embryos; (female sym-
bol) adult females; (male symbol) adult males; gp, gonadal pri-
mordia; cns, central nervous system; sg, salivary gland; id, imagi-
nal discs; nc, nurse cells. (b–d) Anterior is to the right, and dorsal
is up.
Table I. Lethal Phase of scu Alleles
Allele N % D % E % LIII % LP
scu174 77 35 20 — 80
scu4058 150 26 25 — 75
scu3127 113 24 — 75 25
Female scu*/1 were crossed to CS males, and the F1 was analyzed. N, number of an-
alyzed individuals; D, dead individuals; E, embryos; LIII, third instar larvae; LP, late
pupae. Percentages of lethality at each developmental stage refer the total number of
dead individuals.
Figure 5. scully mutant phe-
notypes in testes. Semithin
sections of early brown pupal
testis from (a) scu3127: note
that only few sperm bundles
(sb) and abundant cytoplas-
mic clear inclusions are ob-
served; (b) rescued scu3127:
note that T(2)422E1/T(2)
422E1 displays wild-type
morphology and size (see be-
low the different magnifica-
tion of sections in a–c); and
(c) scu174:  note that it is se-
verely affected and shows
several necrotic cells (nc)
and also numerous lipid in-
clusions. (d) cryostat section
of scu3127 testes stained with
oil red O, showing the lipid
composition of the cytoplas-
mic inclusions. (a and c) Bar,
40 mm; (b) bar, 70 mm; (d)
bar, 15 mm.
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form a proper rhabdomere, and usually contained large
multilayered accumulations of membranous material (Fig.
4 c). Particularly interesting was the abnormality detected
in the mitochondria. They appeared smaller and with
fewer and swollen crestae when compared with neighbor-
ing wild-type cells. This mitochondrial phenotype (pleo-
morphism) is a typical pathology in humans with inherited
b oxidation deficiencies (reviewed in Roe and Coates, 1995).
We also examined the morphological phenotypes in scu
mutant males before onset of lethality. In third instar lar-
vae, we observed a clear reduction of the salivary glands
(not shown). Most striking, however, was the dramatic re-
duction of testes size in all four scu alleles. The degree of
reduction varied in the following order: scu174 . scu4058 .
scuS152 . scu3127. This striking phenotype in testes
prompted a functional assay for HADH activity in these
organs. We analyzed crude extracts from wild-type and
mutant-dissected male gonads, and we detected up to 1022
U/mg of total protein (see Materials and Methods) in the
wild-type extracts, while scu3127 yielded no detectable ac-
tivity. This observation is further evidence that scully en-
codes a HADH activity, and that testes have a specific
requirement for this enzyme. To further study the mor-
phological features of the mutant phenotype, we analyzed
the ultrastructure of testes from either mutant or rescued
early pupae. In wild-type pupal testes when early stages of
spermatogenesis are occurring, spermatocytes are orga-
nized in cysts of 16 cells derived from four mitotic divi-
sions (Fuller, 1993). However, in all scu mutants, sperma-
tocytes were generally organized in smaller groups of
z2–6 cells. Normally, the first cohort of developing spermato-
cytes enters meiosis at about the white prepupal stage, and
forms sperm bundles. Except for scu3127, which contained
few sperm bundles (Fig. 5 a), we did not detect any bundle
of maturing sperm in any of the other scu alleles, even at
the later brown pupal stage. Degenerating spermatocytes
are only occasionally observed in normal testes, but we de-
tected numerous degenerating necrotic cells in scu174 (Fig.
5 c). However, the most remarkable phenotype at the light
microscope was the high amount of clear cytoplasmic vesi-
cles observed in mutant testes cells (Fig. 5, a and c). The
lipid nature of these inclusions was demonstrated after oil
red staining of cryostat sections (Fig. 5 d). The large accu-
mulation of small fat-containing vesicles in the cytoplasm
of mutant spermatocytes was more clearly observed at the
electron microscope (Fig. 6). At this magnification, the
normal eccentric position of nuclei in primary spermato-
cytes was conserved in scu3127 mutants, but the nucleoli of
mutant cells were not as compact as in wild-type cells, and
had many cavities. Moreover, the cytoplasm of the sper-
matocytes normally has a large number of mitochondria,
whereas this number was dramatically reduced in all scu
mutants (Fig. 6 a). Rescued scu3127; T(2)422E1/T(2)422E1
displayed wild-type characteristics. Most strikingly, mito-
chondria were abundant, and steatosis was absent (Figs. 5
b and 6 b).
By mosaic analysis, scu174 has been shown to be lethal in
the female germ line (Ferrús et al., 1990). This together
with the high level of scully expression in the nurse cells of
the ovaries, indicates a requirement for this protein during
oogenesis.
Discussion
scully as a New Member of the Type II HADH Family
In this study we present the molecular and phenotypical
Figure 4. scully mutant phe-
notypes in eye mosaics. (a)
electron photomicrograph
showing a tangential section
of a mosaic eye at the border
of mutant (left) and wild-type
territories. Note the normal
ommatidia (om) showing
the normal complement of
seven photoreceptors in the
wild-type region, while this
number is altered in other
ommatidia near the border
with the mutant area. In the
mutant territory the normal
organization of ommatidia,
and even the normal mor-
phology of photoreceptors, is lost. (b) Higher magnification of normal photoreceptor; and (c) higher magnification of mutant putative
photoreceptor. Note the morphological abnormalities of mitochondria (mt) and the multilayered membrane bodies (mm) in the mutant
cell. rb, rhabdomere. (a) Bar, 5 mm; (b and c) bar, 250 nm.
Table II. Twin Mosaic Analysis of scu Alleles
Allele N
single bristle several bristles
f y f y
scu4058 328 43 9 14 0
scu3127 315 17 4 20 6
The thoracic cuticle of females y w scu* os/f os, that had been irradiated between 0
and 48 h of development (see Materials and Methods), was examined in search for so-
matic recombination clones. Adjacent yellow (y) and forked (f) clones represent the
derivatives of a single recombination event: the y patch is homozygous for scu* muta-
tion; the f patch is the scu1 control. Isolated f clones indicate that the scu mutant cells
have not been able to grow and form the adult structures. Note the severe reduction in
the number of mutant clones obtained with respect to the twin control. N, number of
females analyzed.
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characterization of a Drosophila gene named scully. The
high degree of structural homology between the encoded
product and the biochemically characterized bovine mito-
chondrial 3-l-hydroxyacyl-CoA dehydrogenase type II
(type II HADH) strongly suggests a functional conserva-
tion between these two proteins. The involvement of
Scully in b-oxidation of fatty acids is further supported by
the absence of HADH activity in mutant testes extracts
and the steatosis trait of the mutant phenotype. Other se-
quences of still uncharacterized function in human, mouse,
and Caenorhabditis elegans show strong identity with both
Scully and its bovine homologue, indicating that they may
be counterparts of this enzyme. The human protein
ERAB has been related with Alzheimer’s disease, al-
though its pathological mechanism remains unknown (Yan
et al., 1997). The primary sequence of Scully and its homo-
logues identifies these proteins as members of the SDR
family. This family includes a growing number of proteins
from prokaryotes to mammals, with diverse substrate
specificity but with conserved tertiary structure (reviewed
in Krozowski, 1994 and Jörnvall et al., 1995). Two other
known members of the SDR family in Drosophila melano-
gaster are encoded by the Adh and the Fbp2 genes. While
these genes are closely related to one another, scully dis-
plays low homology with them, indicating a very distant
evolutionary relationship.
scu Mutations and Their Structural Implications
The amino-terminal 16 amino acids of bovine type II
HADH has been proposed as a noncleaved signal that tar-
gets the enzyme into mitochondria (Furuta et al., 1997) by
a mechanism similar to that used by another enzyme of
mitochondrial b-oxidation, the short-chain 3-oxoacyl-CoA
thiolase (Arakawa et al., 1990, Amaya et al., 1988). Com-
parison of the amino-terminal sequence of these proteins
reveals only a loose consensus, but a high number of hy-
drophobic and basic amino acids and a lack of acidic resi-
dues are in common. Although the putative import signal
of Scully is significantly shorter than that of its homo-
logues (10 vs. 15–19 aa, see Fig. 2), it is rich in basic and
hydrophobic residues, suggesting that it might have a si-
milar function. Furthermore, morphological defects ob-
served in mitochondria of scu mutants support a mito-
chondrial localization of Scully.
Downstream from the targeting signal in the primary se-
quences of all members of the SDR family, there is a seg-
ment with three glycine residues. These residues are char-
acteristic of the cofactor (NAD[P]1)-binding fold that is
common to dehydrogenases in general (Rossman et al.,
1975). Structural and mutational analysis indicates that the
adjacent region is also important for cofactor affinity and
specificity (Grimshaw et al., 1992; Tanaka et al., 1996; Na-
kanishi et al., 1997). Interestingly, the scu174 substitution
L33N is located in this area, most likely affecting the
cofactor-binding capacity of the enzyme, and therefore
strongly diminishing its activity. Alternatively, the substi-
tution in scu174 might have a more general effect by dis-
rupting the tertiary structure of the protein. In fact, crys-
tallographic studies of two members of the SDR family
have shown that these proteins form almost identical one-
domain structures in which single substitutions might have
profound effects (Ghosh et al., 1991; Ghosh et al., 1994;
and Varughese et al., 1992).
Several members of the SDR family are known to form
homomultimers. Two a-helices have been identified in
each of two SDR proteins as the subunit-interacting area
that gives strong dimer interactions (Ghosh et al., 1991;
Varughese et al., 1992). Kobayashi et al. (1996) have
shown that bovine type II HADH is a tetramer. The anti-
morphic behavior of three scu mutations (scu174, scu4058,
and scuS152) is consistent with the Scully protein also form-
ing homomultimers. Mutation scu3127 gives rise to a trun-
cated transcript encoding a peptide that contains only the
86 amino-terminal amino acids. This peptide includes the
coenzyme-binding regions, but lacks both the putative in-
teracting domain and the catalytic region. However, al-
though scu3127 should be a functionally null mutation, it
displays the mildest phenotype: absence of embryonic le-
thal phase, larger somatic clones, and weaker testes reduc-
tion. In contrast, the other scu alleles, two of which have
only a single amino acid substitution, and the other of
which has only a small carboxy-terminal deletion, show
more extreme phenotypes. In these latter cases, the hypo-
thetical formation of multimers composed of mutant and
wild-type maternal subunits would result in effective se-
questering of functional monomers into enzymatic com-
plexes with reduced or null activity. The amino acid
change F120I in scuS152 affects an a-helix putatively in-
volved in multimer formation. Therefore, this mutation
may impair formation of the multimer, and may explain
why scuS152 is the least antimorphic allele.
Photoaffinity labeling studies indicate that substrate
specificity of the SDR enzymes is determined to a large
extent by the carboxy-terminal portion of the protein
(Murdock et al., 1986). In fact, this portion is the most
variable region in the SDR family, reflecting the wide vari-
ety of substrates for the different enzymes. Biochemical
analysis of bovine type II HADH have shown that the spe-
cific activity of this enzyme is much higher with longer carbon
chain substrates than that of type I enzyme (apparent Km val-
ues of type II enzyme for substrates other than 3-hydroxy-
Figure 6. Ultrastructure of scu spermatocytes. Electron photomi-
crographs of spermatocytes sections from (a) scu3127; and (b) res-
cued scu3127; T(2)422E1/T(2)422E1. Note the abundance of lipid
inclusions (li) and the lack of mitochondria (mt) in the mutant
spermatocyte. Bar, 2 mm. 
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hexadecanoyl-CoA are higher; Kobayashi et al., 1996). The
strong similarity between Scully and the bovine type II
HADH in their carboxy-terminal regions suggests similar
substrate specificities. scu4058 generates a putative trun-
cated protein lacking this region, and may have lost at
least substrate specificity.
Mutant Phenotype and b-oxidation
One striking observation of the scully subcellular pheno-
type is its similarity with the human pathologies associated
with defective b-oxidation of fatty acids (reviewed in Roe
and Coates, 1995). One of the most characteristic of these
pathologies, mitochondrial pleomorphism, is also ob-
served in mutant scu photoreceptors. Blockade of the
HADH activity leads to strong inhibition of mitochondrial
b-oxidation by direct and feedback effects of the precur-
sors on most enzymatic reactions of the chain (review in
Eaton et al., 1996). As a direct consequence, depletion of
the mitochondrial CoA pool results in arrest of mitochon-
drial fatty acid import and accumulation of lipids in the cy-
toplasm. This phenotype is observed in the testes of all scu
mutants (Fig. 5), and resembles steatosis, another common
pathology caused by b-oxidation deficiencies. Studies in
both invertebrates (Geer et al., 1972) and vertebrates
(Risley, 1990) have shown that there are important meta-
bolic changes in testicular enzymatic activities during sex-
ual maturation. In Drosophila, spermatogonia and sper-
matocytes obtain energy mainly from fatty acids oxidation,
while spermatozoa primarily use carbohydrates and amino
acids as energy sources (Geer et al., 1972). The high re-
quirement for b-oxidation during the first developmental
stages in testes accounts for the phenotypes observed
mostly in the spermatocyte stages in scu mutants. The re-
quirement of Scully for gonad development is also consis-
tent with the high mRNA expression observed in these or-
gans since early developmental stages.
Differential metabolic patterns and energy demands can
also explain both the tissue distribution of the scu tran-
script and the different phenotypes of various cell types.
For example, scu photoreceptors do not show lipid inclu-
sions; instead, rhabdomeres are absent, and cytoplasmic
multi-lamellar bodies are often observed. During photore-
ceptor differentiation, formation of rhabdomeres requires
very active synthesis of lipids; this process needs ATP and
acetyl-CoA, both produced by the b-oxidation pathway.
In this case, the primary defect of scu deficiency could be
related more to phospholipid synthesis alteration than to
energy imbalance.
Several human inherited disorders have been related to
alterations in mitochondrial b-oxidation (see Roe and
Coates, 1995). They are a common cause of exercise-
induced rhabdomyolisis and myoglobinuria (Tonin et al.,
1990). These pathologies, together with other peripheral
neuropathies, have been associated with alterations of the
long-chain HADH (Schaefer et al., 1996). Hepato and car-
diomegalies (Tyni et al., 1997), and retino and acute en-
cephalopathies (Pons et al., 1996) have also been related
with deficiencies of this enzyme. Short-chain type I
HADH alterations have been described in a few cases
(Bennett et al., 1996, Tein et al., 1991), but the enzymatic
defect in several cases with altered oxidation remains un-
characterized. Our results indicate a more stringent re-
quirement of Scully function. Scully is absolutely neces-
sary for normal development in Drosophila, and point
mutations in this protein can have dominant negative ef-
fects. Studies in mammals will be required to understand
the role of this enzyme in mammalian development and
physiology. In this regard, it was recently shown that the
human homologue ERAB mediates neurotoxicity induced
by amyloid-b peptide, and is overexpressed in neurons af-
fected by Alzheimer’s disease (AD; Yan et al., 1997). De-
fects in mitochondrial function have been reported in AD,
and it has been proposed that mitochondrial dysfunction is
a primary causal factor for AD (Sims, 1996). Generation
of reactive oxygen species and disturbances in calcium ho-
meostasis can ultimately lead to cell damage and neuronal
loss in AD. Also, the reduction in the activity of mitochon-
drial pyruvate dehydrogenase observed in AD has been
suggested as a possible cause for the disease-associated
cholinergic deficit through a decrease in acetyl-coA pro-
duction (Hoshi et al., 1997). Therefore, an attractive
model for the role of ERAB in Alzheimer’s pathology is
that the effect of amyloid-b peptide on its enzymatic activ-
ity may result in energy imbalance and/or acetyl-coA de-
pletion, leading to mitochondrial dysfunction and, finally,
neuronal damage.
An intriguing question is that the activity of several en-
zymes of the b-oxidation of fatty acids in the brain in-
crease during the postnatal period in mammals (Reich-
mann et al., 1988; Kelly et al., 1989), even though there are
no evidences that the brain can produce energy from sys-
temic fatty acids. Analysis of scu phenotypes demonstrates
a role of this enzyme, at least in the development of the
photoreceptors, and findings about human ERAB also
support a role in neuronal physiology. Further analysis of
the function of this enzyme in neurons will help us to un-
derstand the role of fatty acid b-oxidation in brain and to
gain new insights into the pathology of some neurodegen-
erative diseases.
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